Our previously published work incorporating IGF-1 into BCLC and CLIP scores showed higher prognostic value [24], and our recently published paper incorporated IGF-1 into MELD score, which significantly improved the score’s ability to predict OS in 2 independent cohorts of HCC patients [25]. Here, IGF1 is linked to hepatocellular carcinoma.